Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · La primera sutura estéril sintética de Johnson & Johnson, la Sutura de Polipropileno PROLENE ®, sigue siendo el patrón-oro para la cirugía de bypass cardíaco por su resistencia, su hilo de sutura seguro y su biocompatibilidad.

    • J. J. Johnson1
    • J. J. Johnson2
    • J. J. Johnson3
    • J. J. Johnson4
    • J. J. Johnson5
  2. Every day, our more than 130,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.

    • J. J. Johnson1
    • J. J. Johnson2
    • J. J. Johnson3
    • J. J. Johnson4
    • J. J. Johnson5
  3. 15 de jul. de 2024 · Mexico has received 43,351,505 doses of ready-to-use vaccines from Pfizer-BioNTech, AstraZeneca, Sinovac, Gamaleya National Research Center of Epidemiology and Microbiology, CanSino and Johnson & Johnson.

  4. 17 de jul. de 2024 · Johnson & Johnson reports Q2 2024 results. • 2024 Second-Quarter reported sales growth of 4.3% to $22.4 Billion with operational growth of 6.6%* and adjusted operational growth of 6.5%*.

  5. 17 de jul. de 2024 · The J&J value. At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal. About Johnson & Johnson.

  6. 13 de jul. de 2024 · Este martes arribaron a México un millón 640 mil 160 dosis de vacunas envasadas, de las cuales un millón 350 mil son Janssen de la farmacéutica Johnson & Johnson y 290 mil 160 de Pfizer-BioNTech, informaron autoridades de Salud y de Relaciones Exteriores, en enlaces vía remota desde los aeropuertos de Toluca y de la Ciudad de México a la ...

  7. 17 de jul. de 2024 · What you need to know about Johnson & Johnsons 2024 second quarter earnings. Here’s an infographic breakdown of the company’s second quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.